Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19

NCT05385029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2022-05-23

No results posted yet for this study

Summary

The thyroid gland has been shown to be a common target for COVID 19 virus. Babies born to mothers positive for COVID 19 infections were noticed to have elevated thyroid stimulating hormone ( TSH ) levels on screening. Thyroid function tests were monitored in these babies to determine presence of temporary or permanent thyroid disorders following COVID 19 infections during pregnancy.

Conditions

Interventions

DRUG

Thyroxine

treatment for hypothyroidism or hyperthyroidism

Sponsors & Collaborators

  • OMER B ABDELBASIT

    lead OTHER

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05385029 on ClinicalTrials.gov